1-197929155-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000367387.6(LHX9):āc.1090G>Cā(p.Asp364His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,868 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 32)
Exomes š: 0.0000068 ( 0 hom. )
Consequence
LHX9
ENST00000367387.6 missense
ENST00000367387.6 missense
Scores
8
7
4
Clinical Significance
Conservation
PhyloP100: 9.57
Genes affected
LHX9 (HGNC:14222): (LIM homeobox 9) This gene encodes a member of the LIM homeobox gene family of developmentally expressed transcription factors. The encoded protein contains a homeodomain and two cysteine-rich zinc-binding LIM domains involved in protein-protein interactions. The protein is highly similar to a mouse protein that causes gonadal agenesis when inactivated, suggesting a role in gonadal development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.41286445).
BS2
High AC in GnomAdExome4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHX9 | NM_020204.3 | c.1090G>C | p.Asp364His | missense_variant | 5/5 | ENST00000367387.6 | NP_064589.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHX9 | ENST00000367387.6 | c.1090G>C | p.Asp364His | missense_variant | 5/5 | 1 | NM_020204.3 | ENSP00000356357 | P1 | |
LHX9 | ENST00000367390.7 | c.1063G>C | p.Asp355His | missense_variant | 6/6 | 1 | ENSP00000356360 | |||
LHX9 | ENST00000367391.5 | c.909+1362G>C | intron_variant | 5 | ENSP00000356361 | |||||
LHX9 | ENST00000561173.5 | c.954+1362G>C | intron_variant | 5 | ENSP00000453064 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151766Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
151766
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250822Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135606
GnomAD3 exomes
AF:
AC:
3
AN:
250822
Hom.:
AF XY:
AC XY:
3
AN XY:
135606
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461102Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 726886
GnomAD4 exome
AF:
AC:
10
AN:
1461102
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
726886
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151766Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74122
GnomAD4 genome
AF:
AC:
2
AN:
151766
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74122
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2023 | The c.1090G>C (p.D364H) alteration is located in exon 5 (coding exon 5) of the LHX9 gene. This alteration results from a G to C substitution at nucleotide position 1090, causing the aspartic acid (D) at amino acid position 364 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;L
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
0.14
.;Gain of glycosylation at T363 (P = 0.0829);
MVP
MPC
1.7
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at